GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Gevo Inc (NAS:GEVO) » Definitions » EBIT
中文

Gevo (GEVO) EBIT

: $-64.05 Mil (TTM As of Dec. 2023)
View and export this data going back to 2011. Start your Free Trial

Gevo's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-17.93 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-64.05 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Gevo's annualized ROC % for the quarter that ended in Dec. 2023 was -25.69%. Gevo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -24.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Gevo's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 109.07%.


Gevo EBIT Historical Data

The historical data trend for Gevo's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gevo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.92 -38.09 -58.95 -96.84 -64.05

Gevo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.68 -17.08 -13.88 -15.16 -17.93

Competitive Comparison

For the Specialty Chemicals subindustry, Gevo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gevo EV-to-EBIT Distribution

For the Chemicals industry and Basic Materials sector, Gevo's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gevo's EV-to-EBIT falls into.



Gevo EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-64.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gevo  (NAS:GEVO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gevo's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-85.348 * ( 1 - 0% )/( (331.953 + 332.614)/ 2 )
=-85.348/332.2835
=-25.69 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=650.322 - 22.752 - ( 298.349 - max(0, 91.426 - 386.382+298.349))
=332.614

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Gevo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-71.724/( ( (239.715 + max(58.43, 0)) + (213.097 + max(63.95, 0)) )/ 2 )
=-71.724/( ( 298.145 + 277.047 )/ 2 )
=-71.724/287.596
=-24.94 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.242 + 3.688 + 80.395) - (22.698 + 0 + 5.197)
=58.43

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.623 + 3.809 + 80.27) - (22.752 + 0 + 0)
=63.95

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Gevo's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-64.054/-58.730
=109.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gevo EBIT Related Terms

Thank you for viewing the detailed overview of Gevo's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Gevo (GEVO) Business Description

Traded in Other Exchanges
Address
345 Inverness Drive South, Building C, Suite 310, Englewood, CO, USA, 80112
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, Net-Zero Segment and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. Gevo Development/Agri-Energy is the key revenue-generating segment that involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.
Executives
Andrew Shafer officer: Chief Mktg Cust & Brnd Officer C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Alisher K Nurmat officer: VP and Controller C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Angelo Amorelli director C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Paul D Bloom officer: CCO & CIO C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Kimberly T Bowron officer: Chief People Officer C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Andrew Marsh director 968 ALBANY SHAKER ROAD, LATHAM NY 12110
Patrick R. Gruber director, officer: CEO & Director C/O GEVO, INC., 345 INVERNESS DR. SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Christopher Michael Ryan officer: EVP, Business Development C/O GEVO, INC., 345 INVERNESS DR. SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Timothy J Cesarek officer: Chief Commercial Officer 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
L Lynn Smull officer: Chief Financial Officer 345 INVERNESS DRIVE S, BLDG C, STE 310, ENGLEWOOD CO 80112
William H Baum director C/O DIVERSA CORP, 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Williams Geoffrey Thomas Jr. officer: General Counsel & Secretary 914 DAKOTA DRIVE, CASTLE ROCK CO 80108
Jaime Guillen director C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Carol Jane Battershell director 1600 NORTH OAK STREET, #918, ARLINGTON VA 22209
Gary W. Mize director GEVO, INC., 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112